Adam McCluskey Selected Research

Botulinum Toxins (Botulinum Toxin)

10/2011

Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam McCluskey Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 02/2003
8	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2007
8	Breast Neoplasms (Breast Cancer) 06/2021 - 09/2011
6	Neuroblastoma 01/2022 - 06/2007
5	Infections 10/2023 - 02/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2019
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 01/2019
2	Leukemia 02/2021 - 12/2020
2	Carcinoma (Carcinomatosis) 09/2016 - 09/2011
2	Colonic Neoplasms (Colon Cancer) 03/2014 - 02/2002
1	Sepsis (Septicemia) 10/2023
1	Staphylococcal Infections 10/2023
1	Peritonitis 10/2023
1	Escherichia coli Infections 10/2023
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Lung Neoplasms (Lung Cancer) 06/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Adenocarcinoma 02/2020
1	Gram-Positive Bacterial Infections 01/2020
1	Soft Tissue Infections 01/2019
1	Otitis Externa 01/2019
1	Glioma (Gliomas) 01/2019
1	HIV Infections (HIV Infection) 01/2017
1	Pain (Aches) 01/2017

Drug/Important Bio-Agent (IBA)

11	Dynamins (Dynamin)IBA 01/2022 - 01/2009
4	RobenidineIBA 10/2023 - 01/2019
4	LigandsIBA 06/2021 - 01/2018
4	norcantharidinIBA 01/2019 - 06/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 05/2021
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2018
3	dynole 34-2IBA 12/2020 - 09/2011
3	GTP Phosphohydrolases (GTPases)IBA 12/2020 - 03/2015
2	Colistin (Coly-Mycin)FDA Link 10/2023 - 05/2021
2	SulfonamidesIBA 10/2023 - 01/2021
2	Edetic Acid (EDTA)FDA Link 01/2020 - 01/2019
2	polymyxin B nonapeptideIBA 01/2020 - 01/2019
2	EstersIBA 09/2016 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 03/2004
2	Phosphates (Orthophosphate)IBA 08/2012 - 09/2011
2	Protein Phosphatase 1IBA 05/2010 - 06/2007
2	Cantharidin (Cantharides)IBA 05/2010 - 06/2007
2	AnhydridesIBA 05/2010 - 02/2003
1	Moxifloxacin (Avelox)FDA Link 10/2023
1	2-aminopyrimidineIBA 10/2023
1	indoleIBA 10/2023
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 06/2021
1	NitrilesIBA 06/2021
1	AcrylonitrileIBA 06/2021
1	Tn receptorIBA 01/2021
1	Appetite Depressants (Anorectics)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	10- chloro- 7H- benzimidazo(2,1- a)benzo(de)Isoquinolin- 7- oneIBA 01/2021
1	isoquinolineIBA 01/2021
1	Peptide YYIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2020
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	Gemcitabine FDA Link 02/2020
1	Drug CombinationsIBA 02/2020
1	Fluorouracil (Carac)FDA LinkGeneric 02/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	aminoflavoneIBA 01/2020
1	AntibodiesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	acetamideIBA 01/2020
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2020
1	AntiemeticsIBA 01/2020
1	bispidinoneIBA 01/2019
1	diphenyl (biphenyl)IBA 01/2019
1	Ether (Diethyl Ether)IBA 01/2019
1	Dynamin IIIBA 01/2019
1	AS 35IBA 01/2018
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Substance PIBA 01/2017
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2017
1	Cytotoxins (Cytolysins)IBA 09/2016
1	AmidesIBA 09/2016
1	BE-26554AIBA 07/2015
1	ChromonesIBA 07/2015
1	furanIBA 07/2015
1	GelsIBA 03/2015
1	CollagenIBA 03/2015
1	oroidinIBA 03/2014
1	Protein Isoforms (Isoforms)IBA 08/2013
1	TropomyosinIBA 08/2013
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2013
1	EllipticinesIBA 02/2013
1	SaltsIBA 02/2013
1	ellipticineIBA 02/2013
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2013
1	pitstop 2IBA 01/2013
1	ClathrinIBA 01/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2020 - 02/2013
1	Oral Administration 10/2023
1	Therapeutics 01/2019